Inmedix, Inc.

Inmedix, Inc. is a Washington-based medical diagnostics company specializing in autonomic nervous system (ANS) assessment through heart rate variability (HRV) analysis. The company manufactures the CloudHRV System, an FDA-cleared clinical diagnostic device that provides medical-grade, 5-minute HRV testing to evaluate both sympathetic (fight-or-flight) and parasympathetic (rest/restorative) neuroregulatory function. The CloudHRV System received FDA clearance in 2025 and is currently deployed across multiple states (Washington, Oregon, Michigan, Florida) with coverage by most major insurance plans. The platform is designed to support precision diagnostics by quantifying autonomic nervous system function, with applications in cardiology and general internal medicine. Inmedix emphasizes the clinical and diagnostic value of HRV measurement and has completed over 1,000 procedures since July 2024. The company's scientific approach focuses on immuno-autonomics and the pathophysiological significance of ANS dysfunction in disease assessment and patient stratification.